Search
                    Cyclophosphamide Treatment Options in Houston, TX
A collection of 516 research studies where Cyclophosphamide is the interventional treatment. These studies are located in the Houston, TX. Cyclophosphamide is used for conditions such as Breast Cancer, Lymphoma and Leukemia.
            469 - 480 of 516
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective for acute lymphoblastic leukemia.
PURPOSE: Phase III trial to determine the effectiveness of combination chemotherapy in treating children who have newly diagnosed acute lymphoblastic leukemia.             
        
        
    Gender:
                ALL
            Ages:
                Between 1 year and 21 years
            Trial Updated:
                02/18/2014
            
            Locations: University of Texas Medical Branch, Galveston, Texas  +2 locations         
        
        
            Conditions: Leukemia
        
            
        
    
                
                                    Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more cancer cells. Bone marrow transplantation allows the doctor to give higher doses of chemotherapy and kill more cancer cells.
PURPOSE: Phase II trial to compare the effectiveness of combination chemotherapy with or without donor bone marrow transplantation in treating infants who have previously untreated acute lymphobla...  Read More             
        
        
    Gender:
                ALL
            Ages:
                1 year and below
            Trial Updated:
                02/18/2014
            
            Locations: University of Texas - MD Anderson Cancer Center, Houston, Texas  +3 locations         
        
        
            Conditions: Leukemia
        
            
        
    
                
                                    Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug and giving them as induction intensification may kill more cancer cells.
PURPOSE: This phase II trial is studying how well induction intensification works in treating infants with newly diagnosed acute lymphocytic leukemia.             
        
        
    Gender:
                ALL
            Ages:
                1 year and below
            Trial Updated:
                02/12/2014
            
            Locations: Texas Tech University Health Sciences Center School of Medicine - Amarillo, Amarillo, Texas  +9 locations         
        
        
            Conditions: Leukemia
        
            
        
    
                
                                    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether chemotherapy is more effective with or without radiation therapy in treating patients who have rhabdomyosarcoma.
PURPOSE: Phase III trial to compare the effectiveness of chemotherapy with or without radiation therapy in treating patients who have newly-diagnosed rhabdomyosarcoma.             
        
        
    Gender:
                ALL
            Ages:
                49 years and below
            Trial Updated:
                02/12/2014
            
            Locations: Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas  +14 locations         
        
        
            Conditions: Sarcoma
        
            
        
    
                
                                    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy combined with radiation therapy in treating patients who have metastatic rhabdomyosarcoma or sarcoma.             
        
        
    Gender:
                ALL
            Ages:
                49 years and below
            Trial Updated:
                02/12/2014
            
            Locations: Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas  +14 locations         
        
        
            Conditions: Sarcoma
        
            
        
    
                
                                    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed neuroblastoma.             
        
        
    Gender:
                ALL
            Ages:
                30 years and below
            Trial Updated:
                02/12/2014
            
            Locations: Baylor College of Medicine, Houston, Texas  +1 locations         
        
        
            Conditions: Neuroblastoma
        
            
        
    
                
                                    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
                                
            
            
        Completed
                            
            
                RATIONALE: Seneca Valley virus-001 may be able to kill certain kinds of tumor cells without damaging normal cells. Adding low dose cyclophosphamide (in part B of study) may help to kill even more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of Seneca Valley virus-001 in treating young patients with relapsed or refractory neuroblastoma, rhabdomyosarcoma, or rare tumors with neuroendocrine features.             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 21 years
            Trial Updated:
                01/29/2014
            
            Locations: Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas  +1 locations         
        
        
            Conditions: Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
        
            
        
    
                
                                    Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
                                
            
            
        Completed
                            
            
                To investigate the safety and efficacy of two dose regimes of ofatumumab in combination with chemotherapy in previously untreated patients with B-CLL             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/19/2013
            
            Locations: GSK Investigational Site, Houston, Texas         
        
        
            Conditions: Leukaemia, Lymphocytic, Chronic
        
            
        
    
                
                                    Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. A bone marrow or peripheral stem cell transplant using stem cells from the patient may be able to replace blood-forming cells that were destroyed by chemotherapy. This may allow more chemotherapy to be given so that more tumor cells are killed.
PURPOSE: This phase III trial is studying how well giving combination chemotherapy with or with...  Read More             
        
        
    Gender:
                ALL
            Ages:
                10 years and below
            Trial Updated:
                12/17/2013
            
            Locations: M. D. Anderson Cancer Center at University of Texas, Houston, Texas         
        
        
            Conditions: Brain and Central Nervous System Tumors
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.             
        
        
    Gender:
                ALL
            Ages:
                21 years and below
            Trial Updated:
                10/15/2013
            
            Locations: Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas  +10 locations         
        
        
            Conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more cancer cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination chemotherapy treatment with more intensive combination chemotherapy in treating children with acute lymphocytic leukemia.             
        
        
    Gender:
                ALL
            Ages:
                Between 1 year and 21 years
            Trial Updated:
                08/23/2013
            
            Locations: University of Texas - MD Anderson Cancer Center, Houston, Texas         
        
        
            Conditions: Leukemia
        
            
        
    
                
                                    Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining carboplatin and vincristine with radiation therapy followed by adjuvant chemotherapy may kill more tumor cells.
PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed adjuvant chemotherapy in tre...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 21 years
            Trial Updated:
                08/22/2013
            
            Locations: University of Texas - MD Anderson Cancer Center, Houston, Texas         
        
        
            Conditions: Brain Tumors, Central Nervous System Tumors, Neuroblastoma
        
            
        
    469 - 480 of 516
            